Published in Dig Dis Sci on June 01, 2004
Current status of mucins in the diagnosis and therapy of cancer. Biofactors (2009) 1.17
Three to Tango: MUC1 as a Ligand for Both E-Selectin and ICAM-1 in the Breast Cancer Metastatic Cascade. Front Oncol (2012) 1.01
Expression of MUC1 and its significance in hepatocellular and cholangiocarcinoma tissue. World J Gastroenterol (2005) 0.99
MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays. J Cancer Res Clin Oncol (2006) 0.97
Humoral immune response to MUC5AC in patients with colorectal polyps and colorectal carcinoma. BMC Gastroenterol (2006) 0.87
Risk factors in malignant transformation of gastric epithelial neoplasia categorized by the revised Vienna classification: endoscopic, pathological, and immunophenotypic features. Gastric Cancer (2010) 0.85
Characterization of nuclear localization and SUMOylation of the ATBF1 transcription factor in epithelial cells. PLoS One (2014) 0.83
Mucin 1 gene (MUC1) and gastric-cancer susceptibility. Int J Mol Sci (2014) 0.82
Interruption of nuclear localization of ATBF1 during the histopathologic progression of head and neck squamous cell carcinoma. Head Neck (2012) 0.81
Relationships between mucinous gastric carcinoma, MUC2 expression and survival. World J Gastroenterol (2006) 0.80
Bile acid induces MUC2 expression and inhibits tumor invasion in gastric carcinomas. J Cancer Res Clin Oncol (2014) 0.80
Mucins in neoplasms of pancreas, ampulla of Vater and biliary system. World J Gastrointest Oncol (2016) 0.79
Clinicopathologic significance of gastric and intestinal phenotypic marker expression in gastric carcinomas. Korean J Intern Med (2005) 0.77
MUC5AC upstream complex repetitive region length polymorphisms are associated with susceptibility and clinical stage of gastric cancer. PLoS One (2014) 0.76
An inverse relationship between the expression of the gastric tumor suppressor RUNX3 and infection with Helicobacter pylori in gastric epithelial dysplasia. Gut Liver (2013) 0.76
MUC1 Immunohistochemical Expression as a Prognostic Factor in Gastric Cancer: Meta-Analysis. Dis Markers (2016) 0.76
MUC2 Expression Is Correlated with Tumor Differentiation and Inhibits Tumor Invasion in Gastric Carcinomas: A Systematic Review and Meta-analysis. J Pathol Transl Med (2015) 0.75
Correlations of Human Epithelial Growth Factor Receptor 2 Overexpression with MUC2, MUC5AC, MUC6, p53, and Clinicopathological Characteristics in Gastric Cancer Patients with Curative Resection. Gastroenterol Res Pract (2015) 0.75
Prognostic value of Muc5AC in gastric cancer: A meta-analysis. World J Gastroenterol (2015) 0.75
Magnifying Endoscopy with Narrow Band Imaging of Early Gastric Cancer: Correlation with Histopathology and Mucin Phenotype. Gut Liver (2016) 0.75
THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand (1965) 22.65
Epithelial mucin genes. Annu Rev Physiol (1995) 4.29
Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res (1993) 3.02
Gastric carcinoma. A pathobiological classification. Cancer (1977) 2.76
Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol (1995) 2.41
Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem Sci (1992) 2.11
Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res (1999) 2.09
Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int J Cancer (1997) 1.69
Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium. Cancer Res (1995) 1.66
Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Clin Cancer Res (1998) 1.66
MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators. Cancer (2001) 1.65
Suppression of cellular aggregation by high levels of episialin. Cancer Res (1992) 1.52
Two novel mucin genes down-regulated in colorectal cancer identified by differential display. Cancer Res (1999) 1.52
Human mucin genes assigned to 11p15.5: identification and organization of a cluster of genes. Genomics (1996) 1.48
Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. J Immunol (1993) 1.40
Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary. J Pathol (1997) 1.34
Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions. Oncology (2001) 1.32
Gastric M1 mucin, an early oncofetal marker of colon carcinogenesis, is encoded by the MUC5AC gene. Int J Cancer (1998) 1.28
Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer (2000) 1.28
Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas. J Histochem Cytochem (2000) 1.25
New elements for an updated classification of the carcinomas of the stomach. Pathol Res Pract (1995) 1.22
Aberrant expression of MUC5AC and MUC6 gastric mucin genes in colorectal polyps. Int J Cancer (1999) 1.20
Differential apomucin expression in normal and neoplastic human gastrointestinal tissues. Gastroenterology (1994) 1.18
Aberrant expression of a human mucin gene (MUC5AC) in rectosigmoid villous adenoma. Gastroenterology (1996) 1.14
Allelic polymorphism and chromosomal localization of the human oviductin gene (MUC9). Fertil Steril (1997) 1.14
Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma. Virchows Arch (2001) 1.13
Expression of fully and under-glycosylated forms of MUC1 mucin in gastric carcinoma. Int J Cancer (1998) 1.11
Chromosomal localization of a human mucin gene (MUC8) and cloning of the cDNA corresponding to the carboxy terminus. Am J Respir Cell Mol Biol (1997) 1.11
Expression of MUC5AC in colorectal carcinoma and relationship with prognosis. Pathol Int (2002) 1.10
Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer. Oncology (1998) 1.09
Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas. Int J Cancer (1998) 1.01
Biosynthesis of mucins (MUC2-6) along the longitudinal axis of the human gastrointestinal tract. Am J Physiol (1997) 0.99
Mucins as key molecules for the classification of intestinal metaplasia of the stomach. Virchows Arch (2001) 0.98
Role of fucosyltransferases in the association between apomucin and Lewis antigen expression in normal and malignant gastric epithelium. Gut (2000) 0.97
Correlation of MUC5AC immunoreactivity with histopathological subtypes and prognosis of gastric carcinoma. Ann Surg Oncol (2002) 0.91
Immunohistochemical detection of gastric mucin in normal and disease states. Oncol Res (1998) 0.88
How do gastric carcinoma classification systems relate to mucin expression patterns? An immunohistochemical analysis in a series of advanced gastric carcinomas. Virchows Arch (2002) 0.88
Detection of the MUC2 apomucin tandem repeat with a mouse monoclonal antibody. Gastroenterology (1993) 0.82
Characterization of four main cell types in gastric cancer: foveolar, mucopeptic, intestinal columnar and goblet cells. An histopathologic, histochemical and ultrastructural study of "early" and "advanced" tumours. Pathol Res Pract (1987) 0.79
The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol (2003) 6.57
Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol (2006) 4.99
Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28. J Clin Oncol (2005) 4.66
Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06. J Clin Oncol (2006) 2.81
Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas. Hum Pathol (2009) 2.64
Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol (2005) 2.17
Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy. J Am Coll Surg (2008) 1.55
Immunohistochemical surrogate markers of breast cancer molecular classes predicts response to neoadjuvant chemotherapy: a single institutional experience with 359 cases. Cancer (2010) 1.48
Use of the breast cancer nomogram to predict non-sentinel nodal positivity in patients having received pre-operative chemotherapy. Ann Surg Oncol (2006) 1.43
Trustworthy alteration and improvement in adjuvant treatment of colon cancer. Med Sci Monit (2006) 1.40
Malignant peripheral nerve sheath tumors of cranial nerves and intracranial contents: a clinicopathologic study of 17 cases. Am J Surg Pathol (2009) 1.36
Breast cancer risk factors in Turkish women--a University Hospital based nested case control study. World J Surg Oncol (2009) 1.36
Factors affecting mortality and morbidity in patients with peptic ulcer perforation. J Gastroenterol Hepatol (2007) 1.31
Expression of MUC5AC in colorectal carcinoma and relationship with prognosis. Pathol Int (2002) 1.10
A Propensity-Matched Analysis of the Influence of Breast Reconstruction on Subsequent Development of Lymphedema. Plast Reconstr Surg (2016) 1.09
Impact of sample acquisition and linear amplification on gene expression profiling of lung adenocarcinoma: laser capture micro-dissection cell-sampling versus bulk tissue-sampling. BMC Med Genomics (2009) 1.08
The association between thyroid carcinoma and Hashimoto's thyroiditis: the ultrasonographic and histopathologic characteristics of malignant nodules. Thyroid (2010) 1.07
Emergent resection for acute sigmoid volvulus: results of 106 consecutive cases. Dis Colon Rectum (2002) 1.04
MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy? Ann Surg Oncol (2011) 1.02
Evaluation of oxidative stress in laparoscopic cholecystectomy. Surg Today (2002) 1.01
Are pretreatment serum albumin and cholesterol levels prognostic tools in patients with colorectal carcinoma? Med Sci Monit (2006) 0.99
Candidate serum biomarkers for prostate adenocarcinoma identified by mRNA differences in prostate tissue and verified with protein measurements in tissue and blood. Clin Chem (2012) 0.97
Semiquantitative hormone receptor level influences response to trastuzumab-containing neoadjuvant chemotherapy in HER2-positive breast cancer. Mod Pathol (2010) 0.97
Follow-up problems and changes in obliteration of the residual cystic cavity after treatment for hepatic hydatidosis. J Hepatobiliary Pancreat Surg (2003) 0.92
The short-term effects of low-level laser therapy in the management of breast-cancer-related lymphedema. Support Care Cancer (2010) 0.92
Factors affecting mortality after hip fracture surgery: a retrospective analysis of 578 patients. Eur J Orthop Surg Traumatol (2012) 0.92
Shared gene expression alterations in prostate cancer and histologically benign prostate from patients with prostate cancer. Am J Pathol (2012) 0.91
Fournier gangrene. Approaches to diagnosis and treatment. Saudi Med J (2006) 0.90
Radioactive seed localization versus wire localization for lumpectomies: a comparison of outcomes. AJR Am J Roentgenol (2015) 0.90
De novo breast cancer in patients with liver transplantation: University of Pittsburgh's experience and review of the literature. Liver Transpl (2004) 0.89
A confirmatory report for the close interaction of Helicobacter pylori with gastric epithelial MUC5AC expression. J Clin Gastroenterol (2004) 0.89
The relationship between prognostic factors of breast cancer and thyroid disorders in Turkish women. J Surg Oncol (2004) 0.88
Endobronchial lipomatous hamartoma: CT and MR imaging features (2004:5b). Eur Radiol (2004) 0.88
The effect of ethyl pyruvate on oxidative stress in intestine and bacterial translocation after thermal injury. J Surg Res (2007) 0.87
Humoral immune response to MUC5AC in patients with colorectal polyps and colorectal carcinoma. BMC Gastroenterol (2006) 0.87
Cavernous haemangioma of small intestine mimicking gastrointestinal stromal tumour. Arab J Gastroenterol (2013) 0.87
The role of serum inflammatory markers in acute appendicitis and their success in preventing negative laparotomy. J Invest Surg (2006) 0.86
Molecular class as a predictor of locoregional and distant recurrence in the neoadjuvant setting for breast cancer. Oncology (2011) 0.85
The effectiveness of early rehabilitation in patients with modified radical mastectomy. Cancer Nurs (2008) 0.85
Breast carcinoma with choriocarcinomatous features. Breast J (2010) 0.84
Distinct postsurgical management in young and elderly breast cancer patients results in equal survival rates. Asian Pac J Cancer Prev (2014) 0.82
Pseudoangiomatous stromal hyperplasia (PASH) of the breast: intraductal appearance. J Obstet Gynaecol Res (2009) 0.82
Atypical hyperplasia on core biopsy: is further surgery needed? Am J Med Sci (2012) 0.82
Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ. Breast J (2007) 0.82
The effect of the excisional biopsy in the detection of the sentinel lymph node by lymphoscintigraphy and intraoperative gamma probe in breast cancer. Mol Imaging Radionucl Ther (2011) 0.80
Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study. Int J Radiat Oncol Biol Phys (2009) 0.80
The protective effect of ethyl pyruvate on lung injury after burn in rats. Saudi Med J (2007) 0.79
Protective effects of trapidil in ischemia-reperfusion injury due to testicular torsion and detorsion: an experimental study. Int J Urol (2006) 0.79
Rationale of excisional biopsy after the diagnosis of benign radial scar on core biopsy: a single institutional outcome analysis. Am J Clin Oncol (2013) 0.78
Factors that predict the burden of axillary disease in breast cancer patients with a positive sentinel node. Am J Clin Oncol (2008) 0.78
Localizing high-risk lesions for excisional breast biopsy: a comparison between radioactive seed localization and wire localization. Ann Surg Oncol (2014) 0.78
Lack of association between RNASEL Arg462Gln variant and the risk of breast cancer. Anticancer Res (2004) 0.77
Serum leptin levels are associated with tamoxifen-induced hepatic steatosis. Curr Med Res Opin (2003) 0.77
Effects of infliximab on bacterial translocation in experimental acute necrotizing pancreatitis. Indian J Med Res (2012) 0.77
Trapidil, an inhibitor for phosphodiesterase and platelet-derived-growth factor, ameliorates corrosive esophageal burn in rats. Tohoku J Exp Med (2005) 0.77
No association between left-breast radiation therapy or breast arterial calcification and long-term cardiac events in patients with breast cancer. J Womens Health (Larchmt) (2014) 0.76
Impact of sentinel lymph node biopsy on lymphedema following breast cancer treatment. Breast J (2005) 0.76
Can nomograms predict non-sentinel lymph node metastasis after neoadjuvant chemotherapy in sentinel lymph node-positive breast cancer patients? Clin Breast Cancer (2009) 0.76
Oxidative Stress and Lipid Peroxidation in the Ischemic Small Intestine: Pathological and Biochemical Evaluation in a Rat model of Superior Mesenteric Ischemia. Int Surg (2014) 0.75
Lightning injuries. South Med J (2003) 0.75
Comparison of Locoregional Recurrence with Mastectomy vs. Breast Conserving Surgery in Pregnancy Associated Breast Cancer (PABC). Cancers (Basel) (2009) 0.75
The role of occupational upper extremity use in breast cancer related upper extremity lymphedema. J Cancer Surviv (2009) 0.75
Lobular carcinoma in situ of the breast and ductoscopy. Breast J (2010) 0.75
The relation between preoperative ultrasonographic thyroid volume analysis and thyroidectomy complications. Endocr Regul (2009) 0.75
Subcutaneous Leiomyosarcoma Metastasized to the Lymph Nodes Involved with Small Lymphocytic Lymphoma / Chronic Lymphocytic Leukemia. Turk Patoloji Derg (2017) 0.75
Intraductal location of the sclerosing adenosis of the breast. Bratisl Lek Listy (2009) 0.75
Does low molecular weight heparin impair anastomotic wound healing? J Gastrointest Surg (2008) 0.75
Type I hereditary punctate keratoderma associated with widespread lentigo simplex and successfully treated with low-dose oral acitretin. Arch Dermatol (2006) 0.75
Yellow nail syndrome: treatment of lymphedema using low pressure compression. Lymphat Res Biol (2012) 0.75
Spontaneous rupture of the rectum with evisceration of small intestine through the anus. J Pak Med Assoc (2008) 0.75
Predicting the likelihood of nonsentinel lymph node metastases in triple negative breast cancer patients with a positive sentinel lymph node: Turkish Federation of Breast Disease Associations protocol MF09-01. Clin Breast Cancer (2011) 0.75
Gingival metastasis of malignant mesenchymal tumour in the thigh. Br J Oral Maxillofac Surg (2003) 0.75
Demographic characteristics of SMA type 1 patients at a tertiary center in Turkey. Eur J Pediatr (2011) 0.75